(Q40730935)

23 September 2017

title

A phase I pharmacokinetic study of recombinant human tumor necrosis factor administered by a 5-day continuous infusion (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1428728

25 September 2022

1 reference

A. Mittelman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1428728

25 September 2022

C. Puccio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1428728

25 September 2022

E. Gafney

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1428728

25 September 2022

N. Coombe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1428728

25 September 2022

B. Singh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1428728

25 September 2022

D. Wood

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1428728

25 September 2022

P. Nadler

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1428728

25 September 2022

T. Ahmed

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1428728

25 September 2022

Z. Arlin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1428728

25 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1428728

25 September 2022

publication date

1 August 1992

1 reference

Investigational New Drugs

23 September 2017

published in

1 reference

23 September 2017

volume

10

1 reference

23 September 2017

issue

3

1 reference

23 September 2017

page(s)

183-190

1 reference

Molecular mechanisms in tumor-cell killing by activated macrophages

23 September 2017

cites work

1 reference

12 December 2020

A monosaccharide precursor of Escherichia coli lipid A has the ability to induce tumor-cytotoxic factor production by a murine macrophage-like cell line, J774.1.

1 reference

12 December 2020

Comparison of in vitro cell cytotoxic assays for tumor necrosis factor

1 reference

12 December 2020

Effect of gamma interferon on cachectin expression by mononuclear phagocytes. Reversal of the lpsd (endotoxin resistance) phenotype

1 reference

12 December 2020

Role of monocyte cytotoxic factor in cytolysis of actinomycin D-treated WEHI 164 cells mediated by freshly isolated human adherent mononuclear blood cells.

1 reference

12 December 2020

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

1 reference

12 December 2020

Phase I trial of intramuscularly administered tumor necrosis factor in patients with advanced cancer

1 reference

12 December 2020

Regulation of the proliferation of the established human monoblast cell line, U937, at the single cell level

1 reference

12 December 2020

Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice

1 reference

12 December 2020

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

1 reference

12 December 2020

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

12 December 2020

Role of mononuclear phagocyte function in endotoxin-induced tumor necrosis

1 reference

12 December 2020

Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism

1 reference

12 December 2020

Molecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factor

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00877244

1 reference

Dimensions Publication ID

23 September 2017

1005967804

0 references

1 reference